TNF and inflammatory bowel disease: PP is generally reported during anti-TNF-α treatment, such as infliximab and adalimumab, in diseases for which anti-TNF-α treatment is indicated, particularly IBD and psoriasis [1,9,16,17,23,32,39,40,41,42,43,44].